Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

22.85 -0.14 (-0.61%)

Delayed Quote Updated: 2:13 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nurix Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 09, 2025

Via Benzinga

What's going on in today's after hours session ↗

July 09, 2025

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout ↗

June 02, 2025

Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib.

Via Benzinga

Breaking Down Nurix Therapeutics: 7 Analysts Share Their Views ↗

April 29, 2025

Via Benzinga

8 Analysts Have This To Say About Nurix Therapeutics ↗

January 29, 2025

Via Benzinga

Decoding 9 Analyst Evaluations For Nurix Therapeutics ↗

December 06, 2024

Via Benzinga

The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts ↗

November 06, 2024

Via Benzinga

Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs ↗

April 23, 2025

On Wednesday, April 23, 2025, Cathie Wood of Ark Invest purchased more stock of AMD and Nvidia amid looming US chip curbs against China.

Via Benzinga

Expert Outlook: Nurix Therapeutics Through The Eyes Of 9 Analysts ↗

April 02, 2025

Via Benzinga

Beyond The Numbers: 8 Analysts Discuss Nurix Therapeutics Stock ↗

March 17, 2025

Via Benzinga

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 ↗

October 31, 2024

The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings.

Via Benzinga

Topics ETFs Stocks

Unveiling 6 Analyst Insights On Nurix Therapeutics ↗

October 11, 2024

Via Benzinga

Analyst Ratings For Nurix Therapeutics ↗

September 04, 2024

Via Benzinga

Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics ↗

July 31, 2024

Via Benzinga

Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday ↗

October 14, 2024

Via Benzinga

Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday ↗

October 14, 2024

Via Benzinga

This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

October 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 10, 2024

Via Benzinga

Nvidia’s Earnings Loom In The Summer Stock Snooze-Fest ↗

August 27, 2024

To the casual observer, stocks look to be drifting around on a Lazy River ride, but the truth is, they’re consolidating their recent gains. This is actually bullish price action.

Via Talk Markets

Analyst Scoreboard: 12 Ratings For Nurix Therapeutics ↗

July 15, 2024

Via Benzinga

Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts ↗

June 27, 2024

Via Benzinga

TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

August 14, 2024

Via Benzinga

Here Is What You Missed On Wall Street On Friday ↗

July 14, 2024

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

Via Talk Markets

Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance ↗

June 21, 2024

The Nasdaq and S&P 500 backed off highs. The Dow regained a key level.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

June 18, 2024

Via Benzinga

Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights ↗

June 05, 2024

Via Benzinga

What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday? ↗

June 17, 2024

Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for...

Via Benzinga

Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

June 17, 2024

Via Benzinga

Biotech Stock Nurix Therapeutics Jumps On Positive Leukemia Treatment Trial ↗

June 17, 2024

San Francisco-based Nurix Therapeutics reported robust results in an ongoing treatment against a stubborn form of leukemia.

Via Investor's Business Daily

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

June 17, 2024

We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning!

Via InvestorPlace

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.